Cancer metastasis: Mechanisms of inhibition by melatonin.
about
Melatonin Reduces Angiogenesis in Serous Papillary Ovarian Carcinoma of Ethanol-Preferring RatsMelatonin, a Full Service Anti-Cancer Agent: Inhibition of Initiation, Progression and Metastasis.Oral Mucositis: Melatonin Gel an Effective New Treatment.MMP-11 promoted the oral cancer migration and Fak/Src activation.A functional variant at the miRNA binding site in HMGB1 gene is associated with risk of oral squamous cell carcinoma.Effects of ADAMTS14 genetic polymorphism and cigarette smoking on the clinicopathologic development of hepatocellular carcinoma.Plasma levels of the tissue inhibitor matrix metalloproteinase-3 as a potential biomarker in oral cancer progressionMelatonin reduces inflammatory response in peripheral T helper lymphocytes from relapsing-remitting multiple sclerosis patients.Inhibitory effects of Leucaena leucocephala on the metastasis and invasion of human oral cancer cells.Melatonin delays photoreceptor degeneration in a mouse model of autosomal recessive retinitis pigmentosa.Association between vascular endothelial growth factor gene polymorphisms and the risk and prognosis of renal cell carcinoma: A systematic review and meta-analysisMelatonin as a Promising Agent to Treat Ovarian Cancer: Molecular Mechanisms.The ABC7 regimen: a new approach to metastatic breast cancer using seven common drugs to inhibit epithelial-to-mesenchymal transition and augment capecitabine efficacy.New MT₂ Melatonin Receptor-Selective Ligands: Agonists and Partial Agonists.High Level of Plasma EGFL6 Is Associated with Clinicopathological Characteristics in Patients with Oral Squamous Cell Carcinoma.Antiproliferative and pro-apoptotic activity of melatonin analogues on melanoma and breast cancer cells.Genetic Variations of Melatonin Receptor Type 1A are Associated with the Clinicopathologic Development of Urothelial Cell Carcinoma.Overexpression of carbonic anhydrase IX induces cell motility by activating matrix metalloproteinase-9 in human oral squamous cell carcinoma cells.Plasma Levels of Endothelial Cell-Specific Molecule-1 as a Potential Biomarker of Oral Cancer Progression.Melatonin as a potential inhibitory agent in head and neck cancer.Andrographolide suppresses the migratory ability of human glioblastoma multiforme cells by targeting ERK1/2-mediated matrix metalloproteinase-2 expression.Melatonin attenuates hypoxia-induced epithelial-mesenchymal transition and cell aggressive via Smad7/ CCL20 in glioma.Association of melatonin membrane receptor 1A/1B gene polymorphisms with the occurrence and metastasis of hepatocellular carcinoma.Inhibiting MT2-TFE3-dependent autophagy enhances melatonin-induced apoptosis in tongue squamous cell carcinoma.Rubus idaeus Inhibits Migration and Invasion of Human Nasopharyngeal Carcinoma Cells by Suppression of MMP-2 through Modulation of the ERK1/2 Pathway.Potentiation of biological effects of mesenchymal stem cells in ischemic conditions by melatonin via upregulation of cellular prion protein expression.Melatonin and health: an umbrella review of health outcomes and biological mechanisms of action.Melatonin prevents endothelial cell pyroptosis via regulation of long noncoding RNA MEG3/miR-223/NLRP3 axis.Impact of HOTAIR Gene Polymorphism and Environmental Risk on Oral Cancer.Melatonin: A Cutaneous Perspective on its Production, Metabolism, and Functions.Impact of microRNA-34a and polymorphism of its target gene CA9 on susceptibility to uterine cervical cancer.Antimetastatic effects of Rheum palmatum L. extract on oral cancer cells.Tricetin suppresses human oral cancer cell migration by reducing matrix metalloproteinase-9 expression through the mitogen-activated protein kinase signaling pathway.Sulforaphane suppresses oral cancer cell migration by regulating cathepsin S expression.Melatonin Inhibits Reactive Oxygen Species-Driven Proliferation, Epithelial-Mesenchymal Transition, and Vasculogenic Mimicry in Oral Cancer.Melatonin suppresses thyroid cancer growth and overcomes radioresistance via inhibition of p65 phosphorylation and induction of ROS.Co-Administration of Melatonin Effectively Enhances the Therapeutic Effects of Pioglitazone on Mesenchymal Stem Cells Undergoing Indoxyl Sulfate-Induced Senescence through Modulation of Cellular Prion Protein Expression.Relationship of genetic variant distributions of WW domain-containing oxidoreductase gene with uterine cervical cancer.Promising Antineoplastic Actions of MelatoninPlk1 promotes the migration of human lung adenocarcinoma epithelial cells via STAT3 signaling
P2860
Q33624518-EA0D14F3-F515-4FE9-BDF0-B740B816CF5BQ33624824-2449A157-1222-4D1F-B40E-580A4E4EDE4CQ33755115-33DD0BBE-084A-423F-A9C0-A82BE136ED4CQ33779252-AF7F1E96-2B4B-4456-BB06-837129292E5AQ33798500-6D0466B3-7EC8-4DF3-A29D-31E1E3B0D85FQ36288548-6D9D15C7-1B8F-4FE8-A5B3-9D82B5E2E682Q37612861-17C65D0D-6B8F-443F-B490-42061FF45092Q38632025-3B14CED0-C46E-44B0-B67C-C6E53FD264C5Q38717161-12013F73-F019-4036-B85B-D2DD16368AEEQ38744273-1E20815F-4DDA-4708-8D88-67138077DAC9Q39295871-868D86EB-7CDE-421B-BEDF-B8883A46F0A9Q39346336-786E95C8-3034-47E8-9573-20709755EBECQ41036251-C4DAB789-C3DD-487D-A5EA-96F4E5BCBE47Q41181255-61E46A09-F9B0-4108-BCC3-C4A7D2077165Q42250454-6430F7F8-F9C6-43AF-BBBB-DCB6797D934BQ42366619-3B3BD989-F3BC-48CC-86F9-EFB3D30351D2Q44284930-59CB2B50-A51E-4051-900E-5A506FF91E20Q47099030-0456F86D-6D3B-49A7-98FF-B18DA2128D51Q47105893-FE144643-C2EA-4880-A302-3A75E33B0559Q47112398-C8DD671D-D09C-4C42-80C6-E7371CB7FACAQ47127766-A83E6BA7-97ED-4C2F-B98D-2C8ADCECE002Q47164243-3AA0883B-6190-42EF-9E0D-7EA22AEEDB38Q47442230-C0EF7313-230A-4466-BC83-4EED96A6933CQ47578133-212B0E5F-A03D-4C42-8190-3CEDD830DE78Q47745693-90FEDC48-F3C9-43F5-A5AD-6DA4D3800E8AQ47991605-26FC6C40-0277-4DA9-9FB8-069C36519E9BQ48109920-D9B95953-AFFB-49AB-BA0F-6DA7FD9F4626Q48200760-E95D34CD-DAFF-4A00-A3B3-3E5006A9DDC3Q49340456-6DC935F4-FAED-460D-A6DF-006B8C3BDC6AQ50083062-7DC73745-7906-4C58-A956-60943D1C3444Q50181237-2E8F38F6-FF66-42D5-AA33-91E45F32DCBAQ50545475-2C909D19-CBDB-4944-A2CB-F599A952A480Q50878067-BC446D04-EDF1-4880-9C2C-95E876563D9DQ54113625-D1E0E9B0-E567-4EBC-B054-A3AF6B2E0371Q54221384-7E1D9F46-2F89-48CD-BF3C-142F15F84069Q54258517-3B701848-5F85-48B1-B012-2DBED534F210Q55001401-6FD1918C-DD4B-419C-A72B-A4A74FDFB708Q55709167-0C33C912-9C00-4E2A-BBAF-160CC9CBF828Q58554204-8027EA54-8B2E-44CD-9F48-E647CBF222A1Q58572055-1A624685-DB9D-4597-8A4E-AE1A363FECFB
P2860
Cancer metastasis: Mechanisms of inhibition by melatonin.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Cancer metastasis: Mechanisms of inhibition by melatonin.
@en
type
label
Cancer metastasis: Mechanisms of inhibition by melatonin.
@en
prefLabel
Cancer metastasis: Mechanisms of inhibition by melatonin.
@en
P2093
P356
P1476
Cancer metastasis: Mechanisms of inhibition by melatonin.
@en
P2093
Ming-Ju Hsieh
Shih-Chi Su
Shun-Fa Yang
Wei-En Yang
Wen-Hung Chung
P356
10.1111/JPI.12370
P577
2016-10-05T00:00:00Z